Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Inhibition of Marfan Syndrome Aortic Root Dilation...
Journal article

Inhibition of Marfan Syndrome Aortic Root Dilation by Losartan Role of Angiotensin II Receptor Type 1–Independent Activation of Endothelial Function

Abstract

Marfan syndrome (MFS) is a genetic disorder that frequently leads to aortic root dissection and aneurysm. Despite promising preclinical and pilot clinical data, a recent large-scale study using antihypertensive angiotensin II (AngII) receptor type 1 (ATR1) blocker losartan has failed to meet expectations at preventing MFS-associated aortic root dilation, casting doubts about optimal therapy. To study the deleterious role of normal ATR1 …

Authors

Sellers SL; Milad N; Chan R; Mielnik M; Jermilova U; Huang PL; de Crom R; Hirota JA; Hogg JC; Sandor GG

Journal

American Journal Of Pathology, Vol. 188, No. 3, pp. 574–585

Publisher

Elsevier

Publication Date

March 2018

DOI

10.1016/j.ajpath.2017.11.006

ISSN

0002-9440